Floatz logo

Autologous Cd34+ Cells Transduced With Tns9.3.55

Severe Combined Immunodeficiency Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)unclassifiedPhase 1/2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Severe Combined Immunodeficiency Syndrome cohort.

Asset / SponsorPhaseRating
Fludarabine
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2/3BB
FILGRASTIM
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2BB
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Washington University School of Medicine
Phase 2/3BB
Busulphan
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2/3BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2/3BB

View all 34 →

Same molecule, other indications

Autologous Cd34+ Cells Transduced With Tns9.3.55 is also rated in:

beta-thalassemia majorDormant
CCC
Indicative ·
54 / 100
View asset →
sickle cell diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
beta thalassemiaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →